Stage IV EGFR Mutated NSCL With Brain Metastases

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00530Erlotinib3Recruiting1
DB00317Gefitinib3Recruiting1
DB11737Icotinib3Recruiting1